Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (20450)	4/14/1999 8:02:00 AM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Frostman...looking for Vivus to expand their work on Gene Therapy beyond the ED market. Can this work improve blood flow to other body parts...improve circulation of blood in Diabetic and others....???????? Now how much would that be worth to avoid the ultimate side effects that some diabetics fear ...loss of a toe,foot,leg?????

To: Frostman who wrote (20450)	4/14/1999 8:41:00 AM
From: RT	Read Replies (2) \| Respond to of 23519

Good Morning Frosty, Hopefully all your hopes will materialize and we will recover from this debacle. I still feel there is hope if the global market materializes and Vivus signs an equitable domestic marketing contract. My biggest fear is that the CEO is incapable of moving the company forward rapidly before additional competition arrives. With limited cash reserves I'm duly concerned that R&D which is the life blood of Vivus might suffer. If that should happens Vivus's days will be numbered. Well let me end on a positive note. Vivus pourrait conquerir le marchè. RT